References
- JurenkaJSAnti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical researchAltern Med Rev200914214115319594223
- MoghadamtousiSZKadirHAHassandarvishPTajikHAbubakarSZandiKA review on antibacterial, antiviral, and antifungal activity of curcuminBiomed Res Int2014201418686424877064
- Bar-SelaGEpelbaumRSchafferMCurcumin as an anti-cancer agent: review of the gap between basic and clinical applicationsCurr Med Chem201017319019720214562
- KumarGMittalSSakKTuliHSMolecular mechanisms underlying chemopreventive potential of curcumin: current challenges and future perspectivesLife Sci201614831332826876915
- WegielLAZhaoYMauerLJEdgarKJTaylorLSCurcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stabilityPharm Dev Technol201419897698624192454
- AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
- LiuWZhaiYHengXOral bioavailability of curcumin: problems and advancementsJ Drug Target201619
- HaniUShivakumarHGSolubility enhancement and delivery systems of curcumin a herbal medicine: a reviewCurr Drug Deliv201411679280425176028
- NaksuriyaOOkonogiSSchiffelersRMHenninkWECurcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatmentBiomaterials201435103365338324439402
- SiddiquiIASannaVImpact of nanotechnology on delivery of natural products for cancer prevention and therapyMol Nutr Food Res20166061330134126935239
- MahmoodKZiaKMZuberMSalmanMAnjumMNRecent developments in curcumin and curcumin based polymeric materials for biomedical applications: a reviewInt J Biol Macromol20158187789026391597
- DreisSRothweilerFMichaelisMCinatlJJrKreuterJLangerKPreparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticlesInt J Pharm20073411–220721417478065
- QuanQXieJGaoHHSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapyMol Pharm2011851669167621838321
- StollenwerkMMPashkunova-MarticIKremserCAlbumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisationHistochem Cell Biol2010133437540420174817
- FabiAGiannarelliDMalagutiPProspective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsDrug Des Devel Ther2015961776183
- WeberCKreuterJLangerKDesolvation process and surface characteristics of HSA-nanoparticlesInt J Pharm2000196219720010699717
- UlbrichKMichaelisMRothweilerFInteraction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cellsInt J Pharm20114061–212813421185364
- LiCLiYGaoYDirect comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?Int J Pharm20144681–2152524709221
- ZhangLHouSMaoSWeiDSongXLuYUptake of folate-conjugated albumin nanoparticles to the SKOV3 cellsInt J Pharm20042871–215516215541922
- ZhaoLDuJDuanYCurcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterizationColloids Surf B Biointerfaces20129710110822609589
- LicciardiMPaolinoDCeliaCGiammonaGCavallaroGFrestaMFolate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugsBiomaterials201031287340735420609469
- MehtaAKYadavKSSawantKKNimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluationCurr Drug Deliv20074318519317627492
- LuHLiBKangYPaclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targetingCancer Chemother Pharmacol200759217518116718469
- ZhangXYLuWYRecent advances in lymphatic targeted drug delivery system for tumor metastasisCancer Biol Med201411424725425610710